Trials / Recruiting
RecruitingNCT05360069
Linear Stapler Versus Circular Stapler in Esophagojejunostomy
Linear Stapler Versus Circular Stapler in Esophagojejunostomy for Patients With Gastric Cancer Underwent Laparoscopic Total Gastrectomy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Nanchong Central Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
With the development of stapler devices, various methods of esophagojejunostomy after laparoscopic total gastrectomy were evoluated. Which stapler is more advantageous has not been determined. At present, the most commonly used is linear stapler or Circular stapler in esophagojejunostomy. However, there is still a lack of reliable evidence for the selection of the two staplers. The purpose of this study is to explore the advantages of linear staper versus circular stapler in esophagojejunostomy for patients with gastric cancer who underwent total gastrectomy.
Detailed description
With the development of stapler devices, various methods of esophagojejunostomy after laparoscopic total gastrectomy were evoluated. Which stapler is more advantageous has not been determined. At present, the most commonly used is linear stapler or Circular stapler in esophagojejunostomy. However, there is still a lack of reliable evidence for the selection of the two staplers. The purpose of this study is to explore the advantages of linear staper versus circular stapler in esophagojejunostomy for patients with Siewert classification type II and III gastric cancer who underwent total gastrectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Linear stapler | Linear stapler is adopted in esophagojejunostomy |
| DEVICE | Circular stapler | Circular stapler is adopted in esophagojejunostomy |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
- First posted
- 2022-05-04
- Last updated
- 2026-04-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05360069. Inclusion in this directory is not an endorsement.